Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test

Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test

There is an ongoing debate as to whether SARS-CoV-2 antibodies can be found in patients who have recovered from COVID-19 disease. Currently, there is no consensus on whether the antibodies, if present, are protective. Our regular measurements of SARS-CoV-2 antibodies, starting in July 2020, have pro...

Full description

Bibliographic Details
Main Authors: Václav Šimánek, Ladislav Pecen, Zuzana Krátká, Tomáš Fürst, Hana Řezáčková, Ondřej Topolčan, Karel Fajfrlík, Dalibor Sedláček, Robin Šín, Petr Pazdiora, Hana Zelená, David Slouka, Radek Kučera
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Diagnostics
Subjects:
antibody
SARS-CoV-2
spike protein
nucleocapsid protein
serological diagnostics
immunoassay
Online Access:https://www.mdpi.com/2075-4418/11/4/593

Internet

https://www.mdpi.com/2075-4418/11/4/593

Similar Items